Non-oncology Biopharmaceuticals Market Key Drivers and Forecast 2025-2032
Non-oncology Biopharmaceuticals Market Trends And Drivers The Non-oncology Biopharmaceuticals Market was valued at USD 314.5 Billion in 2022 and is projected to reach USD 670.3 Billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030. This market encompasses a broad range of biopharmaceuticals, excluding oncology therapies, and includes segments like autoimmune disease […]
Continue Reading